Company Filing History:
Years Active: 2012
Title: Jan Eickhoff: Innovator in Cancer Treatment
Introduction
Jan Eickhoff is a notable inventor based in Munich, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on creating effective therapies that target specific kinases involved in tumor proliferation.
Latest Patents
Jan Eickhoff holds a patent for Raf inhibitors, which are derivatives of pyrido[2,3-d]pyrimidin-7-one. This invention provides compounds that act as inhibitors of kinases such as Raf. These compounds demonstrate anti-proliferative activity, particularly against tumor cells, making them valuable in the treatment of various diseases, including cancer.
Career Highlights
Eickhoff is currently associated with Forma Therapeutics, Inc., where he continues to advance his research in oncology. His work has been instrumental in developing new therapeutic options for patients suffering from cancer.
Collaborations
Jan Eickhoff collaborates with talented professionals in his field, including colleagues Andreas Schoop and Alexander Backes. Their combined expertise contributes to the innovative environment at Forma Therapeutics, Inc.
Conclusion
Jan Eickhoff's contributions to cancer treatment through his patented Raf inhibitors highlight his role as a leading inventor in the pharmaceutical industry. His ongoing work promises to enhance therapeutic strategies for combating cancer.